Stronger Part News Today

Teaching them that we dont always, we might not always _ teaching them that we dont always, we might not always win, _ teaching them that we dont always, we might not always win, but - teaching them that we dont always, we might not always win, but we - teaching them that we dont always, i we might not always win, but we take part, we might not always win, but we take part. have _ we might not always win, but we take part. have a _ we might not always win, but we take part. have a go. — we mig...

16 of this world cup. health chiefs urge parents of toddlers to vaccinate their children against the flu, after an increase in hospital admissions. close to collapsing into chaos. that is the warning from business leaders across the north of england, where 80% of rail services have been cancelled this year. they say it could get worse before christmas. then theyre is meeting the government later to say enough is enough. another grey, misty and cold day across most of the uk. a few sunny spots. g...

Perfect drug, but in a very modest way it— perfect drug, but in a very modest way it can — perfect drug, but in a very modest way it can slow the decline from alzheimers. so even though it is very modest, that is highly significant.— very modest, that is highly siunificant. �* , significant. and they say is an international _ significant. and they say is an international story _ significant. and they say is an international story in - significant. and they say is an international story i...

In memory and understanding. david is one of nearly 2,000 patients who took part in a major trial of a new drug — lecanemab. as normal, if you just - lift your arm up there for me. it involved having an infusion every two weeks. lecanemab didnt stop alzheimers... illjust get you started here. ..but over 18 months, its slowed its progression by about a quarter. this is so exciting because now were getting results, - the first results that - are indicating that the drug is successfully treating ...

No, its not. so, some of those who took— no, its not. so, some of those who took part— no, its not. so, some of those who took part suffered brain swelling and also — took part suffered brain swelling and also bleeds in the brain. so patients— and also bleeds in the brain. so patients need to be carefully monitored. but i can tell you that the patients i might like david, and another— the patients i might like david, and another couple, who didnt know whether— another couple, who did...

Possible _ people who can benefit as quickly as possible. that is what we at alzheimers research uk will be lobbying — alzheimers research uk will be lobbying for. alzheimers research uk will be lobbying for-— alzheimers research uk will be lobb in: for. lobbying for. people here in the uk took art lobbying for. people here in the uk took part in — lobbying for. people here in the uk took part in the _ lobbying for. people here in the uk took part in the trial _ lobbying for. people here i...

Where all our short—term memory is stored. - alzheimers gradually destroys key areas of the brain involved in memory and understanding. david is one of nearly 2,000 patients who took part in a major trial of a new drug — lecanemab. as normal, if you just - lift your arm up there for me. it involved having an infusion every two weeks. lecanemab didnt stop alzheimers... illjust get you started here. ..but over 18 months, its slowed its progression by about a quarter. this is so exciting becaus...

We need to keep developing these younger players through, and thats going to be the plan. cash marcus rashford scored two of englands goals — including this stunning free—kick. it takes him to three goals at the tournament — the joint—highest—scorer. a really special moment for him after he celebrated. as part of his celebration he pointed to the sky and explained why. unfortunately, i lost one of my friends a couple of days ago — hes had quite a long battle with cancer, so its... yo...

That the progression of early stage alzheimers disease can be slowed down. nearly 2000 patients took part in the study, including some in the uk. full results have been published in the new england journal of medicine. the treatment is called lecanemab. its effects were small, but have still prompted huge excitement among researchers. 0ur medical editor, fergus walsh, reports. could you get the broccoli out of the fridge for me, please, love? yeah. ok. david essam is 78 and has early stage alzhe...